A dynamic C-suite executive and proven CEO, leading 6 diverse B2B and B2C businesses to record growth and profit in both public and private enterprises, ranging from start up to $1 billion in revenue. Original and current C-suite member of a biotechnology company developing and commercializing a breakthrough cancer diagnostic. Industry experience includes healthcare, direct to consumer and wholesale consumer products, media, and entertainment. Developed and executed digitally innovative strategies to transform businesses and accelerate growth. Deep expertise and a novel approach to impactful branding and business development via strategic alliances of scale across multiple stakeholder groups and industry sectors. Exceptional communicator, able to formulate and deliver highly resonant messaging to promote and differentiate businesses to bot internal and external constituents. A collaborative leader with a strong commercial track record, attracting and retaining top talent to develop results-driven executive teams. Member of the Women’s Leadership Board of the Harvard Kennedy School’s Women and Public Policy Program since 2015 and nominated to serve on the Executive Committee of the Board from 2019 to present. Received numerous national leadership and commercialization awards and selected for the Distinguished Speaker Series at Harvard, Yale, Wharton and Columbia. Served as Board Director for eight businesses and organizations.
